Partner: Agata Klejman

Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)

Recent publications
1.Zdioruk M., Want A., Mietelska-Porowska A., Laskowska-Kaszub K., Wojsiat J., Klejman A., Użarowska E., Koza P., Olejniczak S., Pikul S., Konopka W., Golab J., Wojda U., A new inhibitor of tubulin polymerization kills multiple cancer cell types and reveals p21-mediated mechanism determining cell death after mitotic catastrophe, Cancers, ISSN: 2072-6694, DOI: 10.3390/cancers12082161, Vol.12, No.8, pp.2161-1-21, 2020
Abstract:

Induction of mitotic catastrophe through the disruption of microtubules is an established target in cancer therapy. However, the molecular mechanisms determining the mitotic catastrophe and the following apoptotic or non-apoptotic cell death remain poorly understood. Moreover, many existing drugs targeting tubulin, such as vincristine, have reduced efficacy, resulting from poor solubility in physiological conditions. Here, we introduce a novel small molecule 2-aminoimidazoline derivative-OAT-449, a synthetic water-soluble tubulin inhibitor. OAT-449 in a concentration range from 6 to 30 nM causes cell death of eight different cancer cell lines in vitro, and significantly inhibits tumor development in such xenograft models as HT-29 (colorectal adenocarcinoma) and SK-N-MC (neuroepithelioma) in vivo. Mechanistic studies showed that OAT-449, like vincristine, inhibited tubulin polymerization and induced profound multi-nucleation and mitotic catastrophe in cancer cells. HeLa and HT-29 cells within 24 h of treatment arrested in G2/M cell cycle phase, presenting mitotic catastrophe features, and 24 h later died by non-apoptotic cell death. In HT-29 cells, both agents altered phosphorylation status of Cdk1 and of spindle assembly checkpoint proteins NuMa and Aurora B, while G2/M arrest and apoptosis blocking was consistent with p53-independent accumulation in the nucleus and largely in the cytoplasm of p21/waf1/cip1, a key determinant of cell fate programs. This is the first common mechanism for the two microtubule-dissociating agents, vincristine and OAT-449, determining the cell death pathway following mitotic catastrophe demonstrated in HT-29 cells.

Keywords:

cancer, chemotherapeutic, microtubule-poison, vincristine, mitotic catastrophe, non-apoptotic cell death, p21, p53

Affiliations:
Zdioruk M.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Want A.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Mietelska-Porowska A.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Laskowska-Kaszub K.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Wojsiat J.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Klejman A.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Użarowska E.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Koza P.-other affiliation
Olejniczak S.-OncoArendi Therapeutics (PL)
Pikul S.-OncoArendi Therapeutics (PL)
Konopka W.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Golab J.-Medical University of Warsaw (PL)
Wojda U.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
2.Koza P., Przybyś J., Klejman A., Olech-Kochańczyk G., Konopka W., Generation of transgenic rats using a lentiviral vector approach, Journal of Visualized Experiments, ISSN: 1940-087X, DOI: 10.3791/60570, Vol.159, pp.e60570-1-8, 2020
Abstract:

Transgenic animal models are fundamentally important for modern biomedical research. The incorporation of foreign genes into early mouse or rat embryos is an invaluable tool for gene function analysis in living organisms. The standard transgenesis method is based on microinjecting foreign DNA fragments into a pronucleus of a fertilized oocyte. This technique is widely used in mice but remains relatively inefficient and technically demanding in other animal species. The transgene can also be introduced into one-cell-stage embryos via lentiviral infection, providing an effective alternative to standard pronuclear injections, especially in species or strains with a more challenging embryo structure. In this approach, a suspension that contains lentiviral vectors is injected into the perivitelline space of a fertilized rat embryo, which is technically less demanding and has a higher success rate. Lentiviral vectors were shown to efficiently incorporate the transgene into the genome to determine the generation of stable transgenic lines. Despite some limitations (e.g., Biosafety Level 2 requirements, DNA fragment size limits), lentiviral transgenesis is a rapid and efficient transgenesis method. Additionally, using female rats that are mated with a fertile male strain with a different dominant fur color is presented as an alternative to generate pseudopregnant foster mothers.

Keywords:

retraction, issue 159, transgenic rat, lentiviral vectors, perivitelline space, foster mothers

Affiliations:
Koza P.-other affiliation
Przybyś J.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Klejman A.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Olech-Kochańczyk G.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Konopka W.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
3.Was H., Barszcz K., Czarnecka J., Kowalczyk A., Bernas T., Uzarowska E., Koza P., Klejman A., Piwocka K., Kaminska B., Sikora E., Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice, Oncotarget, ISSN: 1949-2553, DOI: 10.18632/oncotarget.14066, Vol.8, No.6, pp.9303-9322, 2017
Abstract:

Anticancer therapies that induce DNA damage tend to trigger senescence in cancer cells, a process known as therapy-induced senescence (TIS). Such cells may undergo atypical divisions, thus contributing to tumor re-growth. Accumulation of senescent cancer cells reduces survival of patients after chemotherapy. As senescence interplays with autophagy, a dynamic recycling process, we sought to study whether inhibition of autophagy interferes with divisions of TIS cells. We exposed human colon cancer HCT116 cells to repeated cycles of a chemotherapeutic agent - doxorubicin (doxo) and demonstrated induction of hallmarks of TIS (e.g. growth arrest, hypertrophy, poliploidization and secretory phenotype) and certain properties of cancer stem cells (increased NANOG expression, percentages of CD24+ cells and side population). Colonies of small and highly proliferative progeny appeared shortly after drug removal. Treatment with bafilomycin A1 (BAF A1), an autophagy inhibitor, postponed short term in vitro cell re-population. It was associated with reduction in the number of diploid and increase in the number of poliploid cells. In a long term, a pulse of BAF A1 resulted in reactivation of autophagy in a subpopulation of HCT116 cells and increased proliferation. Accordingly, the senescent HCT116 cells treated with BAF A1 when injected into NOD/SCID mice formed tumors, in contrast to the controls. Our results suggest that senescent cancer cells that appear during therapy, can be considered as dormant cells that contribute to cancer re-growth, when chemotherapeutic treatment is stopped. These data unveil new mechanisms of TIS-related cancer maintenance and re-population, triggered by a single pulse of BAF A1 treatment.

Keywords:

colon cancer, chemotherapy, senescence, autophagy, angiogenesis

Affiliations:
Was H.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Barszcz K.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Czarnecka J.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Kowalczyk A.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Bernas T.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Uzarowska E.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Koza P.-other affiliation
Klejman A.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Piwocka K.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Kaminska B.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Sikora E.-Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)